Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Female Breast Cancer Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00003877
What this trial is testing

Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Roswell Park Cancer Institute 30
Very early researchLooking for participantsNCT06305962
What this trial is testing

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

Who this might be right for
PDL1 Gene MutationNon Small Cell Lung CancerSmall Cell Lung Cancer ( SCLC )+6 more
Radiopharm Theranostics, Ltd 30
Testing effectiveness (Phase 2)Study completedNCT04588935
What this trial is testing

Prevention of Cardiovascular Diseases Caused by Complex Treatment of Patients With Primary Operated Breast Cancer

Who this might be right for
Women With Breast Cancer
State Institution "Republican Scientific and Practical Center" Cardiology, Belarus 100
Early research (Phase 1)Looking for participantsNCT06582017
What this trial is testing

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

Who this might be right for
Ovarian CancerPancreas CancerUrothelial Carcinoma+6 more
Nammi Therapeutics Inc 100
Early research (Phase 1)Study completedNCT00361049
What this trial is testing

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Cancer
Case Comprehensive Cancer Center 49
Early research (Phase 1)WithdrawnNCT04602117
What this trial is testing

ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer

Who this might be right for
HER2-positive Breast CancerHER2 LowSYD-985+24 more
QuantumLeap Healthcare Collaborative
Testing effectiveness (Phase 2)Ended earlyNCT03149549
What this trial is testing

PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors

Who this might be right for
Solid Tumor, AdultBreast CancerNon Small Cell Lung Cancer+2 more
CytomX Therapeutics 99
Testing effectiveness (Phase 2)Study completedNCT00052351
What this trial is testing

Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)WithdrawnNCT00397501
What this trial is testing

BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerCognitive/Functional Effects+2 more
OHSU Knight Cancer Institute
Early research (Phase 1)Study completedNCT00623831
What this trial is testing

Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen

Who this might be right for
MelanomaSarcomaGastrointestinal Stromal Tumor (GIST)+6 more
Ludwig Institute for Cancer Research 17
Early research (Phase 1)UnknownNCT03076372
What this trial is testing

A Study Evaluating MM-310 in Patients With Solid Tumors

Who this might be right for
Solid TumorsUrothelial CarcinomaGastric Carcinoma+9 more
Merrimack Pharmaceuticals 34
Not applicableEnded earlyNCT02483377
What this trial is testing

Patient Navigation and Tailored Treatment Planning in Latina Patients With Breast Cancer

Who this might be right for
Breast Carcinoma
University of Southern California 13
Early research (Phase 1)Study completedNCT00622674
What this trial is testing

Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+5 more
Masonic Cancer Center, University of Minnesota 37
Early research (Phase 1)Ended earlyNCT04178460
What this trial is testing

Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment

Who this might be right for
Gastric CancerTriple Negative Breast CancerBiliary Tract Carcinoma+1 more
Zai Lab (Shanghai) Co., Ltd. 60
Large-scale testing (Phase 3)Study completedNCT04822597
What this trial is testing

Pain Control for Breast Cancer Patients Receiving Injection of Radioactive Tracer

Who this might be right for
Breast CancerSentinel Lymph NodeBreast Neoplasms+1 more
University of Wisconsin, Madison 167
Not applicableStudy completedNCT04436809
What this trial is testing

Sentinel Node Biopsy Alone or With Axillary Dissection After Primary Chemotherapy

Who this might be right for
Breast Neoplasm Female
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 353
Not applicableEnded earlyNCT00651716
What this trial is testing

T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more
Vanderbilt-Ingram Cancer Center 150
Early research (Phase 1)Study completedNCT00471432
What this trial is testing

OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors

Who this might be right for
Bladder CancerBreast CancerKidney Cancer+4 more
NCIC Clinical Trials Group 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03384914
What this trial is testing

Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer

Who this might be right for
Breast Cancer FemaleBreast Cancer, MaleBreast Cancer Stage I+5 more
H. Lee Moffitt Cancer Center and Research Institute 119
Post-approval studies (Phase 4)Study completedNCT03583944
What this trial is testing

Evaluate Safety, Tolerability and Efficacy of Eribulin Mesylate in Treating Adult Females With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Eisai Inc. 200
Next Page